These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 31600177
21. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma. Hu S, Hinson JL, Matnani R, Cibull ML, Karabakhtsian RG. Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301 [Abstract] [Full Text] [Related]
22. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. McCluggage WG, Oliva E, Herrington CS, McBride H, Young RH. Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729 [Abstract] [Full Text] [Related]
26. SATB2 is Consistently Expressed in Squamous Morules Associated With Endometrioid Proliferative Lesions and in the Stroma of Atypical Polypoid Adenomyoma. McCluggage WG, Van de Vijver K. Int J Gynecol Pathol; 2019 Sep; 38(5):397-403. PubMed ID: 30085940 [Abstract] [Full Text] [Related]
30. Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma. Zaidi A, Gupta P, Gupta N, Rajwanshi A, Rai B, Gainder S. Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):42-48. PubMed ID: 31815745 [Abstract] [Full Text] [Related]
36. Stromal signatures in endometrioid endometrial carcinomas. Espinosa I, Catasus L, D' Angelo E, Mozos A, Pedrola N, Bértolo C, Ferrer I, Zannoni GF, West RB, van de Rijn M, Matias-Guiu X, Prat J. Mod Pathol; 2014 Apr 01; 27(4):631-9. PubMed ID: 24263966 [Abstract] [Full Text] [Related]
37. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas. Weisman P, Park KJ, Xu J. Int J Gynecol Pathol; 2022 Mar 01; 41(2):126-131. PubMed ID: 33811207 [Abstract] [Full Text] [Related]
38. p16 expression in the female genital tract and its value in diagnosis. O'Neill CJ, McCluggage WG. Adv Anat Pathol; 2006 Jan 01; 13(1):8-15. PubMed ID: 16462152 [Abstract] [Full Text] [Related]
40. Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites. Gilks CB, Clement PB, Hart WR, Young RH. Int J Gynecol Pathol; 2000 Jul 01; 19(3):195-205. PubMed ID: 10907166 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]